Cytokinetics (CYTK) Change in Cash (2010 - 2026)

Cytokinetics (CYTK) has reported Change in Cash for 17 consecutive years, with $7.3 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Change in Cash rose 134.58% year-over-year to $7.3 million; the TTM figure through Mar 2026 stood at $58.9 million (up 227.22% YoY), while the FY2025 annual figure was $30.4 million, up 267.34% from the prior year.
• Change in Cash grew to $7.3 million in Q1 2026 per CYTK's latest filing, from -$102.9 million in the prior quarter.
• Across five years, Change in Cash topped out at $152.0 million in Q3 2025 and bottomed at -$143.3 million in Q3 2024.
• Historically, Change in Cash has averaged $1.2 million across 5 years, with a median of $7.0 million in 2024.
• Annual changes were most pronounced in 2023 — Change in Cash surged 1207.47% — and 2024, when it tumbled 561.32%.
• Cytokinetics' Change in Cash stood at -$39.1 million in 2022, then soared by 134.14% to $13.3 million in 2023, then jumped by 259.8% to $48.0 million in 2024, then slumped by 314.61% to -$102.9 million in 2025, then soared by 107.11% to $7.3 million in 2026.
• Business Quant data shows CYTK's Change in Cash at $7.3 million in Q1 2026, -$102.9 million in Q4 2025, and $152.0 million in Q3 2025.